Fingerprint
Dive into the research topics of 'Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically